CC
ChampionX Corp (CHX)·Q1 2025 Earnings Summary
Executive Summary
- Q1 2025 revenue was $864.5M, diluted EPS $0.44 and adjusted EPS $0.50; adjusted EBITDA was $190.9M (22.1% margin). Sequential declines reflected normal seasonality in international operations, while margins remained resilient given productivity and mix .
- Consolidated revenue fell 5% q/q and 6% y/y; adjusted EBITDA margin improved y/y to 22.1% from 20.8% despite lower volumes, underscoring cost discipline and pricing/productivity actions .
- Company discontinued quarterly guidance and did not host an earnings call due to the pending all‑stock acquisition by SLB; US HSR review is complete and closing now targeted end-Q1/early Q2 2025, with a definitive agreement to divest US Synthetic at close .
- Operational highlights included EPA approval of ChampionX Emissions Technologies’ Aerial Optical Gas Imaging (AOGI) platform under OOOOb, multiple Middle East first‑fill wins, and sustained digital product traction (XSPOC, SMARTEN XE/Lite) .
- Wall Street consensus from S&P Global was unavailable for Q1 2025 due to a Capital IQ mapping issue; estimate comparison could not be performed. Note: Estimates unavailable via S&P Global (CIQ mapping) [GetEstimates error].
What Went Well and What Went Wrong
What Went Well
- Adjusted EBITDA margin reached 22.1%, the second-highest level as ChampionX, supported by productivity and profitability focus: “we delivered adjusted EBITDA of $191 million, representing a 22.1% adjusted EBITDA margin” .
- Reservoir Chemical Technologies grew revenue 23% q/q to $26.9M; operating margin expanded 1008 bps q/q to 20.5% on higher volumes and favorable mix .
- Strategic and regulatory milestones: EPA approval of AOGI as a Methane Alternative Test Method under OOOOb, enabling scalable methane detection for operators (component‑level platform approved) .
What Went Wrong
- Consolidated revenue decreased 5% q/q to $864.5M, driven primarily by typical seasonal decline in international operations (notably impacting Production Chemical Technologies) .
- Production Chemical Technologies margins compressed q/q (operating −248 bps to 15.7%; adjusted EBITDA −259 bps to 20.8%) on lower volumes .
- Drilling Technologies margins contracted q/q (operating to 16.2% from 20.6%; adjusted EBITDA margin down 346 bps) due to lower North America volumes .
Financial Results
Consolidated Headline Metrics (oldest → newest)
Year-over-Year (Q1 2025 vs Q1 2024)
Segment Breakdown (Revenue and Margins)
KPIs and Cash Flow
Guidance Changes
Earnings Call Themes & Trends
Note: Company did not host an earnings call for Q1 2025 due to pending SLB acquisition .
Management Commentary
- “We delivered strong adjusted EBITDA and adjusted EBITDA margin, and generated positive free cash flow… the resilience of our ChampionX portfolio” — Soma Somasundaram, President & CEO .
- “Revenue of $864 million… decreased 5% sequentially… driven primarily by a typical seasonal decline in international operations” .
- “We are leveraging our global and flexible supply chain footprint, long-standing supplier partnerships, pricing adjustments, and productivity initiatives to address tariff impacts” .
- “Ending the first quarter with approximately $1.2 billion of liquidity, including $527 million of cash and $674 million of available capacity on our revolving credit facility” .
Q&A Highlights
- No Q&A — company discontinued quarterly guidance and did not host a conference call or webcast due to the pending SLB acquisition .
Estimates Context
- Wall Street consensus via S&P Global could not be retrieved for Q1 2025 due to a Capital IQ mapping issue; therefore, beat/miss vs consensus is not available. Note: Estimates unavailable via S&P Global (CIQ mapping) [GetEstimates error].
- Given the absence of estimates, investors should focus on sequential and year‑over‑year trends: q/q −5% revenue on seasonality; y/y −6% revenue with flat adjusted EPS at $0.50 and slightly lower adjusted EBITDA .
Key Takeaways for Investors
- Margin resilience despite volume headwinds: adjusted EBITDA margin 22.1% in Q1, up vs Q1 2024 (20.8%), reflecting productivity and pricing/mix execution .
- Seasonal patterns matter: international seasonality drove the q/q revenue decline; watch 2H normalization potential in Production Chemical Technologies .
- Strategic overhang and timeline: SLB acquisition progressing (HSR expired), closing now expected end‑Q1/early Q2; US Synthetic divestiture set to close in conjunction with the transaction — a key catalyst path .
- Emissions tech portfolio strengthening: EPA approval of AOGI under OOOOb enhances regulatory credibility and could accelerate adoption of emissions monitoring solutions in 2025 .
- Reservoir Chemical Technologies inflection: strong q/q revenue/margin expansion on higher volumes and favorable mix — monitor sustainability of this momentum .
- Digital product traction persisted through seasonality: $57.8M Q1 digital revenue; continued deployments of XSPOC and SMARTEN solutions support recurring/attached revenue streams .
- Cash generation intact though seasonal dip: FCF $38.6M and CFO $66.8M; liquidity remained robust at ~$1.2B, supporting dividends ($0.095/sh) and strategic flexibility into close .